Does Preference-based HIV Testing Increase Uptake in High Risk Populations?

NACompletedINTERVENTIONAL
Enrollment

1,194

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2020

Conditions
HIV Testing
Interventions
BEHAVIORAL

PB-HCT +

Participants will be offered 3 HIV testing options. The investigators will rank the predicted utility of all EXISTING HIV testing options for each participant and select those 3 PB-HCT options that jointly maximize the share of participants predicted to prefer at least one of the three options over the common option.

BEHAVIORAL

PB-HCT -

Participants will be offered 3 HIV testing options. The investigators will rank the predicted utility of all feasible HIV testing options for each participant and select 3 PB-HCT options that are less preferred than the common option

BEHAVIORAL

Economic incentive

Participants will be re-contacted three months after being offered PB-HCT options. Participants will be reminded of the options, and offered an incentive to present for testing using any of the PB-HCT options or the common option.

BEHAVIORAL

PB-HCT ++

Participants will be offered 3 HIV testing options. The investigators will rank the predicted utility of all feasible ENHANCED HIV testing options for each participant and select those 3 PB-HCT options that jointly maximize the share of participants predicted to prefer at least one of the three options over the common option.

BEHAVIORAL

SMS Reminder

Participants will receive an SMS reminder to test.

Trial Locations (3)

27708

Duke University, Durham

29208

University of South Carolina, Columbia

Unknown

Kilimanjaro Clinical Research Institute, Moshi

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Duke University

OTHER

collaborator

Kilimanjaro Christian Medical Centre, Tanzania

OTHER

lead

University of South Carolina

OTHER

NCT02714140 - Does Preference-based HIV Testing Increase Uptake in High Risk Populations? | Biotech Hunter | Biotech Hunter